Anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitors rarely elicit complete responses in patients with advanced ALK-rearranged non-small cell lung cancer (NSCLC), as a small population of tumor ...

Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is an aggressive, molecularly distinct leukemia subtype marked by menin-dependent transcriptional dysregulation, poor response to ...

Immunohistochemistry was performed on 4-μm-thick formalin-fixed, paraffin-embedded tumor sections. All CIC-rearranged sarcomas were stained with ERG and CD31 antibodies if not already conducted at ...